Tirzepatide 10mg is a dual GIP and GLP-1 receptor agonist being developed for the treatment of type 2 diabetes. As a leading manufacturer, we provide high quality Tirzepatide 10mg with 99% purity for research applications.
Our Tirzepatide 10mg is produced under strict quality control standards in cGMP compliant facilities. The product undergoes comprehensive analytical testing including HPLC, MS, and NMR to ensure identity, purity and potency.
Available packaging options include 10 vials per box (5mg, 10mg or 15mg per vial) with the flexibility for custom packaging configurations. We offer bulk quantities for research institutions and pharmaceutical developers.
The Tirzepatide 10mg peptide demonstrates excellent stability when stored properly at -20°C. This product is intended for research use only, not for human consumption.
Key advantages of our Tirzepatide 10mg include batch-to-batch consistency, comprehensive analytical documentation, and reliable global shipping. We support both small-scale research needs and large pharmaceutical development projects.
For researchers studying diabetes treatments, our Tirzepatide 10mg offers a reliable source of this promising peptide with demonstrated effects on glucose control and weight management in preclinical studies.